Maligne Speicheldrüsentumoren – Highlights der ASCO-Jahrestagung 2019
Author:
Publisher
Springer Science and Business Media LLC
Subject
Otorhinolaryngology
Link
http://link.springer.com/content/pdf/10.1007/s00106-019-00760-9.pdf
Reference13 articles.
1. Badlani J, Gupta R, Balasubramanian D et al (2018) Primary salivary gland malignancies: a review of clinicopathological evolution, molecular mechanisms and management. ANZ J Surg 88:152–157. https://doi.org/10.1111/ans.14201
2. Boukheris H, Curtis RE, Land CE, Dores GM (2009) Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United States. Cancer Epidemiol Biomarkers Prev 18:2899–2906. https://doi.org/10.1158/1055-9965.EPI-09-0638
3. El-Khoueiry AB, Desai J, Iyer SP et al (2018) A phase I study of AL101, a pan-NOTCH inhibitor, in patients (pts) with locally advanced or metastatic solid tumors. J Clin Oncol 36:2515. https://doi.org/10.1200/JCO.2018.36.15_suppl.2515
4. Fayette J, Even C, Digue L et al (2019) NISCAHN: A phase II, multicenter nonrandomized trial aiming at evaluating nivolumab (N) in two cohorts of patients (pts) with recurrent/metastatic (R/M) salivary gland carcinoma of the head and neck (SGCHN), on behalf of the Unicancer Head & Neck Group. J Clin Oncol 37:6083. https://doi.org/10.1200/JCO.2019.37.15_suppl.6083
5. Ferrarotto R, Ho AL, Wirth LJ et al (2019) ACCURACY: phase (P) 2 trial of AL101, a pan-Notch inhibitor, in patients (pts) with recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC) with Notch activating mutations (Notchact mut). J Clin Oncol 37:TPS6098. https://doi.org/10.1200/JCO.2019.37.15_suppl.TPS6098
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Neue Therapieansätze für Speicheldrüsenmalignome;TumorDiagnostik & Therapie;2023-04-26
2. Neue Therapieansätze für Speicheldrüsenmalignome;Laryngo-Rhino-Otologie;2022-03-23
3. A Contemporary Review of Molecular Therapeutic Targets for Adenoid Cystic Carcinoma;Cancers;2022-02-16
4. Mutational and immunologic Landscape in malignant Salivary Gland Tumors harbor the potential for novel therapeutic strategies;Critical Reviews in Oncology/Hematology;2022-02
5. Seltene Erkrankungen der Speicheldrüsen und des Nervus Facialis;Laryngo-Rhino-Otologie;2021-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3